Where does Octave Bioscience's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Octave Bioscience's 5 recorded funding rounds.

Premier Alternatives

Octave Bioscience

Menlo Park, CA · Founded 2014 · Privately Held (backing)

Operator of a biomarker-driven precision medicine company intended to improve monitoring and treatment decisions for neurodegenerative diseases. Octave Bioscience is based in Menlo Park, CA and was founded in 2014. Its last reported valuation was $143 million in Jul 2023. It has raised $129 million across 5 recorded rounds; the latest was a $31.8 million early-stage round in Mar 2025.

Last reported valuation

$143.0M

Oct 2026

Priced at

—

Total raised

$129.2M

Last round

Early Stage VC

Mar 2025

Cap table — not yet on record

Octave Bioscience's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of Octave Bioscience with a free account

·The complete investor list: 18 names
·Watch Octave Bioscience: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about Octave Bioscience

Where does Octave Bioscience's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Octave Bioscience's 5 recorded funding rounds.